Operating Cash Flow
Zimmer Biomet Holdings Operating Cash Flow decreased by 30.5% to $359.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.1%, from $382.80M to $359.40M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $453.90M | $433.10M | $365.70M | $315.70M | $345.50M | $450.80M | $244.20M | $307.70M | $347.90M | $337.60M | $588.40M | $228.00M | $369.40M | $395.70M | $506.30M | $382.80M | $378.20M | $418.70M | $517.40M | $359.40M |
| QoQ Change | — | -4.6% | -15.6% | -13.7% | +9.4% | +30.5% | -45.8% | +26.0% | +13.1% | -3.0% | +74.3% | -61.3% | +62.0% | +7.1% | +28.0% | -24.4% | -1.2% | +10.7% | +23.6% | -30.5% |
| YoY Change | — | — | — | — | -23.9% | +4.1% | -33.2% | -2.5% | +0.7% | -25.1% | +141.0% | -25.9% | +6.2% | +17.2% | -14.0% | +67.9% | +2.4% | +5.8% | +2.2% | -6.1% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's operating cash flow?
- Zimmer Biomet Holdings (ZBH) reported operating cash flow of $359.40M in Q1 2026.
- How has Zimmer Biomet Holdings's operating cash flow changed year-over-year?
- Zimmer Biomet Holdings's operating cash flow decreased by 6.1% year-over-year, from $382.80M to $359.40M.
- What is the long-term trend for Zimmer Biomet Holdings's operating cash flow?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's operating cash flow has grown at a 3.1% compound annual growth rate (CAGR), from $1.50B to $1.70B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.